Antitumor activity of MLN4924, a novel small molecule inhibitor of Nedd8-activating enzyme, in pre-clinical models of lymphoma

被引：0
|
作者：
Smith, Peter G. [1 ]
Milhollen, Michael [1 ]
Traore, Tary [1 ]
Zhang, Julie [1 ]
Berger, Allison [1 ]
Yu, Jie [1 ]
Garnsey, James [1 ]
Langston, Steve [1 ]
Soucy, Teresa [1 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3602S / 3602S
页数：1
相关论文
共 50 条
  • [31] Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma
    Shah, Jatin J.
    Jakubowiak, Andrzej J.
    O'Connor, Owen A.
    Orlowski, Robert Z.
    Harvey, R. Donald
    Smith, Mitchell R.
    Lebovic, Daniel
    Diefenbach, Catherine
    Kelly, Kevin
    Hua, Zhaowei
    Berger, Allison J.
    Mulligan, George
    Faessel, Helene M.
    Tirrell, Stephen
    Dezube, Bruce J.
    Lonial, Sagar
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 34 - 43
  • [32] Evaluation of MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, as a novel targeted agent with single-agent antitumor activity in mantle cell lymphoma (MCL) and Hodgkin lymphoma preclinical models.
    Dawar, Richa
    Barth, Matthew John
    Mavis, Cory
    Skitzki, Jospeh J.
    Czuczman, Myron Stefan
    Klener, Pavel
    Hernandez-Ilizaliturri, Francisco J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
    Luo, Zhongguang
    Yu, Guangyang
    Lee, Hyuk Woo
    Li, Lihui
    Wang, Lingyan
    Yang, Dongqin
    Pan, Yongfu
    Ding, Chan
    Qian, Jing
    Wu, Lijun
    Chu, Yiwei
    Yi, Jing
    Wang, Xiangdong
    Sun, Yi
    Jeong, Lak Shin
    Liu, Jie
    Jia, Lijun
    CANCER RESEARCH, 2012, 72 (13) : 3360 - 3371
  • [34] Genome-wide screen for modulators of cell death induced by the NEDD8-activating enzyme inhibitor MLN4924
    Cosmopoulos, Kat
    Blank, Jonathan
    Liu, Xiaozhen
    Bouck, David
    Garcia, Khristofer
    Liao, Hua
    Bernard, Hughes
    Tayber, Olga
    Hather, Greg
    Liu, Ray
    Lightcap, Eric
    CANCER RESEARCH, 2012, 72
  • [35] The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth via triggering autophagy
    Lv, Yongzhu
    Li, Bing
    Han, Kunna
    Xiao, Yang
    Yu, Xianjun
    Ma, Yong
    Jiao, Zhan
    Gao, Jianjun
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2018, 22 (06): : 617 - 625
  • [36] A Quantitative Proteomic Analysis Identifies Neddylated Proteins Regulated by the Investigational NEDD8-activating Enzyme Inhibitor MLN4924
    Liu, X.
    Blank, J.
    Liao, H.
    Lightcap, E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 114 - 114
  • [37] MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor, Induces Differentiation in Acute Myelogenous Leukemia Cell Lines
    Thomas, M. P.
    Milhollen, M. A.
    Naryanan, U.
    McDonald, A.
    Fleming, M.
    Amidon, B.
    Manfredi, M.
    Smith, P. G.
    Berger, A. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 88 - 88
  • [38] Evaluation of the Anti-Tumor Activity of MLN4924, A Novel NEDD8 Activating Enzyme Inhibitor, in Pre-Clinical Models of Rituximab Chemotherapy-Sensitive or -Resistant B-Cell Lymphoma
    Czuczman, Natalie M.
    Barth, Matthew J.
    Dwar, Richa
    Mavis, Cory
    Klener, Pavel, Jr.
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2012, 120 (21)
  • [39] MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study
    Lin, Wei-Chou
    Kuo, Kuan-Lin
    Shi, Chung-Sheng
    Wu, June-Tai
    Hsieh, Ju-Ton
    Chang, Hong-Chiang
    Liao, Shih-Ming
    Chou, Chien-Tso
    Chiang, Chih-Kang
    Chiu, Wei-Shuo
    Chiu, Tzu-Yuan
    Pu, Yeong-Shiau
    Ho, I-Lin
    Wang, Zuo-He
    Chang, Shih-Chen
    Liu, Shing-Hwa
    Jeng, Yung-Ming
    Huang, Kuo-How
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (11): : 3350 - 3362
  • [40] THE FIRST-IN-CLASS SMALL MOLECULE INHIBITOR OF NEDD8-ACTIVATING ENZYME (NAE), MLN4924, INDUCES STABLE DISEASE REGRESSION IN PRECLINICAL MODELS OF ACUTE MYELOID LEUKEMIA (AML)
    Carew, J.
    Swords, R.
    Kelly, K.
    Smith, P.
    Garnsey, J.
    Mahalingam, D.
    Medina, E.
    O'Dwyer, M.
    Oberheu, K.
    Nawrocki, S.
    Giles, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 183 - 183
12345